News and Insights of 3D Printing and Manufacturing
Atomstack, a Chinese intelligent manufacturing technology company, released its Cambrian line of desktop rubber 3D printers, a first for desktop printing. The printers promise greater prototyping and faster production of customized rubber items.
Denise Vicentin, a Brazilian cancer survivor who lost her right eye and part of her jaw, has received a facial prosthesis develop using a 3D printed prototype.
FossiLabs, a US-based medical 3D printing start-up, has announced the launch of its FFF 3D printed bone-like scaffolding structures using a porous PEEK material. Reportedly the first ‘fully’ porous 3D printed PEEK porous medical implants, the bone-like structures are designed to be used within implantable devices using Fossilabs’ proprietary hardware and software.
The impact of pandemic continued to dominate the headlines in the 3D printing industry during September. Whether it be the cancellation of industry events, or the efforts of additive manufacturers to help fight the disease, COVID-19 was never far from the news.
To Our Regular and New Clients, As the end of year draws near, we would like to take th ...
In this edition of Sliced, the 3D Printing Industry news digest, we cover the latest business developments, partnerships, and acquisitions across the additive manufacturing industry.
Biomedical researchers from Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) and The University of Texas at El Paso (UTEP) are collaborating to develop artificial mini-hearts using 3D bioprinting technology for space.
Leading 3D printer OEM 3D Systems and Israeli bioprinting material developer CollPlant have announced a joint development agreement seeking to create tissue and scaffold bioprinting solutions for third party collaborators.
Walmart has partnered with SmileDirectClub, a Nashville-based teledentistry company that uses 3D printing to make aligners, to exclusively offer its line of oral care products.
3D printed patient-specific airway stents, developed by a doctor at Cleveland Clinic, a nonprofit multispecialty academic medical center in Ohio, has received clearance from the U.S. Food and Drug Administration (FDA).